We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+4.41%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$42.6B
AUM Growth
+$4.82B
Cap. Flow
+$3.68B
Cap. Flow %
8.65%
Top 10 Hldgs %
12.95%
Holding
2,932
New
107
Increased
1,463
Reduced
1,212
Closed
134

Sector Composition

Rank Sector Weight
1 Technology 12.83%
2 Financials 12.17%
3 Healthcare 10.88%
4 Industrials 10.2%
5 Consumer Discretionary 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MITK icon
2651
Mitek Systems
MITK
$767M
$103K ﹤0.01%
10,911
+46
+0.4% +$449
ABR icon
2652
Arbor Realty Trust
ABR
$993M
$102K ﹤0.01%
12,407
+84
+0.7% +$684
IPI icon
2653
Intrepid Potash
IPI
$447M
$101K ﹤0.01%
2,331
+7
+0.3% +$236
LCTX icon
2654
Lineage Cell Therapeutics
LCTX
$277M
$98K ﹤0.01%
39,492
+1,788
+5% +$4.43K
RCS
2655
PIMCO Strategic Income Fund
RCS
$248M
$98K ﹤0.01%
10,041
-1,443
-13% -$14.5K
ACGN
2656
DELISTED
Aceragen Inc
ACGN
$95K ﹤0.01%
314
+81
+35% +$21.2K
HDSN
2657
Hudson Technologies
HDSN
$262M
$94K ﹤0.01%
12,099
+47
+0.4% +$407
CTLP
2658
DELISTED
Cantaloupe
CTLP
$89K ﹤0.01%
14,396
+2,264
+19% +$12.2K
GAB icon
2659
Gabelli Equity Trust
GAB
$1.77B
$88K ﹤0.01%
13,911
-99,829
-88% -$609K
DRRX
2660
DELISTED
DURECT Corp
DRRX
$85K ﹤0.01%
4,854
+10
+0.2% +$168
ZIXI
2661
DELISTED
Zix Corporation
ZIXI
$84K ﹤0.01%
17,339
+69
+0.4% +$364
CDR
2662
DELISTED
Cedar Realty Trust, Inc
CDR
$83K ﹤0.01%
2,209
-287
-11% -$9.75K
VIA
2663
DELISTED
Viacom Inc. Class A
VIA
$82K ﹤0.01%
2,228
-1,796
-45% -$69.7K
XXII
2664
22nd Century Group
XXII
$1.45M
0
CDXS icon
2665
Codexis
CDXS
$156M
$78K ﹤0.01%
11,804
+42
+0.4% +$232
BBG
2666
DELISTED
Bill Barrett Corp
BBG
$77K ﹤0.01%
18,202
-358
-2% -$1.19K
EPM icon
2667
Evolution Petroleum
EPM
$129M
$76K ﹤0.01%
10,437
+48
+0.5% +$364
TTI icon
2668
TETRA Technologies
TTI
$1.15B
$76K ﹤0.01%
27,025
+4,131
+18% +$10.1K
DNR
2669
DELISTED
Denbury Resources, Inc.
DNR
$75K ﹤0.01%
56,564
+3,878
+7% +$5.05K
AVEO
2670
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$75K ﹤0.01%
2,064
+14
+0.7% +$433
MEET
2671
DELISTED
The Meet Group, Inc. Common Stock
MEET
$74K ﹤0.01%
20,471
+77
+0.4% +$328
VATE icon
2672
INNOVATE Corp
VATE
$99.6M
$72K ﹤0.01%
1,374
+45
+3% +$2.4K
WFT
2673
DELISTED
Weatherford International plc
WFT
$72K ﹤0.01%
15,693
-23,419
-60% -$96.8K
KNDI
2674
Kandi Technologies Group
KNDI
$69.9M
$70K ﹤0.01%
12,217
+223
+2% +$945
EGLE
2675
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$69K ﹤0.01%
2,202
+39
+2% +$1.24K

Similar funds

Guggenheim Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Guggenheim Capital held 2,932 positions worth $42.6B, up 13% from $37.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Guggenheim Capital deployed $3.68B of net new capital in Q3 2017, opening 107 new positions and adding to 1,463 existing holdings. Its largest new stake was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF: 1,677,943 shares worth $84.5M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $46.6M trimmed.

  • Guggenheim Capital's largest Q3 2017 buy was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF: 1,677,943 shares worth $84.5M.
  • Guggenheim Capital added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2017, an estimated $209M increase.
  • Guggenheim Capital's biggest Q3 2017 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $46.6M.
  • Guggenheim Capital fully exited Reynolds American Inc in Q3 2017, selling an estimated $68.3M.
  • Guggenheim Capital's ten largest holdings make up 13% of its $42.6B portfolio in Q3 2017.
  • Guggenheim Capital opened 107 new positions and closed 134 in Q3 2017.
  • Guggenheim Capital's portfolio value rose 13% quarter-over-quarter to $42.6B.

Based on Guggenheim Capital's 13F filing for Q3 2017, filed 14 Nov 2017.